rxstat › Shortages › Gabapentin

Gabapentin (Neurontin) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Nov 5, 2026

Some Gabapentin products are in shortage in Canada (27 of 79 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jan 27, 2027.

An anticonvulsant used to treat nerve pain and certain types of seizures.

Products affected
27 / 79
In shortage since
Apr 11, 2014
Est. full return
Jan 27, 2027
Reports on file
243
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
APO-GABAPENTIN
300MG · CAPSULE · APOTEX INC
DIN 02244305 · since Oct 27, 2026, est. end Dec 4, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-GABAPENTIN
400MG · CAPSULE · APOTEX INC
DIN 02244306 · since Oct 13, 2026, est. end Dec 4, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-GABAPENTIN
400MG · CAPSULE · APOTEX INC
DIN 02244306 · since Oct 6, 2026, est. end Dec 4, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-GABAPENTIN
100MG · CAPSULE · APOTEX INC
DIN 02244304 · since Oct 6, 2026, est. end Dec 4, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-GABAPENTIN
100MG · CAPSULE · APOTEX INC
DIN 02244304 · since Sep 29, 2026, est. end Dec 4, 2026 · Disruption of the manufacture of the drug.
Active shortage
GLN-GABAPENTIN
600MG · TABLET TABLET (IMMEDIATE RELEASE) · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02410990 · since ?, no end estimate · Health Canada sales restriction
Active shortage
GLN-GABAPENTIN
800MG · TABLET TABLET (IMMEDIATE RELEASE) · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02411008 · since ?, no end estimate · Health Canada sales restriction
Active shortage
GABAPENTIN
600MG · TABLET · SANIS HEALTH INC
DIN 02431289 · since ?, no end estimate · Disruption of the manufacture of the drug.
Active shortage
NEURONTIN
800MG · TABLET · BGP PHARMA ULC
DIN 02239718 · since Jan 5, 2026, est. end Jan 5, 2027 · Shortage of an active ingredient.
Active shortage
NEURONTIN
400MG · CAPSULE · BGP PHARMA ULC
DIN 02084287 · since Feb 2, 2026, est. end Jan 5, 2027 · Shortage of an active ingredient.
Active shortage
PRO-GABAPENTIN
800MG · TABLET · PRO DOC LIMITEE
DIN 02310481 · since Jul 29, 2026, est. end Jan 27, 2027 · Disruption of the manufacture of the drug.
Active shortage
PRO-GABAPENTIN
600MG · TABLET · PRO DOC LIMITEE
DIN 02310473 · since Jun 19, 2026, est. end Jan 27, 2027 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Gabapentin is currently affected by 27 active shortage reports filed with Health Canada by APOTEX INC, GLENMARK PHARMACEUTICALS CANADA INC., SANIS HEALTH INC, BGP PHARMA ULC and 7 others.

The reported causes are: disruption of the manufacture of the drug; health canada sales restriction; shortage of an active ingredient; requirements related to complying with good manufacturing practices; delay in shipping of the drug; not bringing new supply; supply discontinued due to low demand; demand is low, not ordered in recent months. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Recent changes

Common questions

What is Gabapentin used for?

An anticonvulsant used to treat nerve pain and certain types of seizures.

When will Gabapentin be back in stock in Canada?

The latest manufacturer estimate is Jan 27, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Gabapentin in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Acetylsalicylic Acid (Asatab) Partial shortage 5 of 17 reported products affected Caffeine Acetylsalicylic Acid (Anacin Extra Strength) Partial shortage 1 of 2 reported products affected Pregabalin (Lyrica) Partial shortage 16 of 80 reported products affected · est. return May 16, 2028 Acetaminophen (Pediatrix) Widespread shortage 14 of 26 reported products affected · est. return Feb 19, 2027 Caffeine Acetylsalicylic Acid Butalbital (Pronal) Widespread shortage 2 of 3 reported products affected · est. return Nov 30, 2026 Acetaminophen Caffeine Discontinued 0 of 1 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.